Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2010. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
The filing discloses a specific transaction involving Mr. D S Redfern:
- Transaction: Purchase of 2,850 Ordinary shares of GlaxoSmithKline plc.
- Date of Transaction: 19 May 2009.
- Purpose: Shares to be held in trust on behalf of his two children.
- Notification Date: The Company was advised of this transaction on 28 January 2010.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share transaction noted above.
Investor Verification Points
- Verify the total shareholding of Mr. D S Redfern following the purchase of 2,850 shares.
- Confirm the trust structure details regarding the shares held for his children.
- Note that this filing does not reflect the company's operational or financial status for the period.